NPI: 1205811221 · EAU CLAIRE, WI 54701 · General Acute Care Hospital · NPI assigned 12/13/2005
Authorized official ALLEN, PATRICIA controls 18+ related entities in our dataset. Read more
| Authorized Official | ALLEN, PATRICIA (CFO) |
| NPI Enumeration Date | 12/13/2005 |
Other providers sharing the same authorized official: ALLEN, PATRICIA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 52,535 | $995K |
| 2019 | 42,490 | $830K |
| 2020 | 43,300 | $712K |
| 2021 | 58,606 | $843K |
| 2022 | 62,334 | $986K |
| 2023 | 66,439 | $1.10M |
| 2024 | 8,757 | $171K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 9,853 | 8,616 | $581K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 9,448 | 8,098 | $414K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,651 | 3,046 | $408K |
| 80053 | Comprehensive metabolic panel | 16,008 | 12,123 | $377K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,369 | 3,022 | $249K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,641 | 3,242 | $242K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,302 | 2,904 | $203K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,824 | 2,006 | $196K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,109 | 4,408 | $186K |
| 80306 | 3,158 | 2,613 | $154K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,379 | 2,970 | $152K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 3,137 | 2,571 | $138K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,963 | 2,703 | $124K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 21,267 | 15,039 | $123K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5,064 | 3,603 | $103K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,760 | 1,560 | $98K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,903 | 2,586 | $92K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,847 | 1,643 | $92K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,902 | 2,585 | $88K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 742 | 675 | $87K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,404 | 1,258 | $77K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 852 | 432 | $70K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,209 | 1,018 | $66K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,194 | 862 | $63K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,975 | 1,370 | $58K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,930 | 4,320 | $56K |
| 82948 | 6,556 | 2,407 | $46K | |
| 84484 | 5,799 | 3,936 | $46K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 764 | 686 | $45K |
| G0378 | Hospital observation service, per hour | 2,265 | 1,388 | $43K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1,404 | 1,260 | $41K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 706 | 612 | $41K |
| 87507 | 122 | 115 | $39K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 846 | 393 | $38K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,330 | 2,111 | $38K |
| 81025 | 3,675 | 3,112 | $35K | |
| 88142 | 1,984 | 1,783 | $35K | |
| 87430 | 922 | 817 | $34K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2,601 | 2,276 | $30K |
| 87077 | 2,545 | 2,106 | $27K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 328 | 297 | $26K |
| 81001 | 6,951 | 5,979 | $26K | |
| 96367 | 461 | 261 | $24K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,029 | 942 | $23K |
| 86140 | 5,077 | 4,042 | $22K | |
| 87653 | 640 | 602 | $20K | |
| 83735 | 5,025 | 3,701 | $19K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 352 | 298 | $19K |
| 83880 | 1,361 | 1,192 | $18K | |
| 83690 | 3,618 | 3,080 | $18K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 238 | 95 | $17K |
| 83605 | 2,299 | 1,705 | $16K | |
| 81003 | 3,660 | 3,202 | $16K | |
| 87040 | 2,610 | 1,298 | $15K | |
| 87205 | 2,247 | 1,868 | $15K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 419 | 372 | $13K |
| 87088 | 2,004 | 1,776 | $13K | |
| 87186 | 2,094 | 1,680 | $13K | |
| 84702 | 544 | 394 | $13K | |
| 86803 | 1,107 | 1,007 | $13K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 262 | 237 | $13K |
| 71046 | Radiologic examination, chest; 2 views | 2,851 | 2,557 | $12K |
| 87070 | 1,139 | 939 | $11K | |
| 74018 | 991 | 851 | $11K | |
| 85610 | 4,419 | 3,398 | $11K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 787 | 729 | $10K |
| 85379 | 1,417 | 1,258 | $9K | |
| 87081 | 1,446 | 1,335 | $9K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 145 | 127 | $8K |
| 84439 | 872 | 799 | $8K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 108 | 95 | $6K |
| 82565 | 567 | 423 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5,340 | 4,398 | $6K |
| 85730 | 2,292 | 1,926 | $6K | |
| 80050 | General health panel | 1,371 | 1,166 | $5K |
| 84145 | 410 | 340 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 74 | 65 | $5K |
| 82607 | 402 | 364 | $5K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 29 | 24 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | 653 | 576 | $4K |
| 87808 | 365 | 323 | $4K | |
| 87340 | 550 | 473 | $4K | |
| 71045 | Radiologic examination, chest; single view | 4,015 | 3,466 | $4K |
| 82550 | 736 | 604 | $4K | |
| 83550 | 586 | 515 | $4K | |
| 85027 | 531 | 432 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5,451 | 3,360 | $3K |
| 83540 | 688 | 600 | $3K | |
| 86618 | 240 | 199 | $3K | |
| 86850 | 593 | 480 | $3K | |
| 87807 | 133 | 120 | $3K | |
| 93458 | 15 | 12 | $3K | |
| 93971 | 149 | 131 | $3K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 83 | 76 | $2K |
| 72125 | Computed tomography, cervical spine; without contrast material | 171 | 147 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,173 | 3,603 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 59 | 50 | $2K |
| 84703 | 295 | 267 | $2K | |
| 86780 | 249 | 217 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7,495 | 6,148 | $2K |
| 82247 | 18 | 14 | $2K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 322 | 88 | $2K |
| 73610 | 186 | 161 | $1K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 34 | 26 | $1K |
| 86900 | 833 | 676 | $1K | |
| 86901 | 834 | 676 | $1K | |
| 73564 | 136 | 116 | $1K | |
| 82803 | 53 | 40 | $942.60 | |
| 82728 | 71 | 65 | $895.18 | |
| 82570 | 164 | 143 | $842.73 | |
| G0379 | Direct admission of patient for hospital observation care | 34 | 26 | $831.42 |
| 59025 | Fetal non-stress test | 15 | 13 | $811.62 |
| 97161 | 25 | 25 | $695.83 | |
| 85018 | 357 | 257 | $650.24 | |
| 83970 | 30 | 27 | $639.31 | |
| 73630 | 231 | 201 | $631.96 | |
| 84100 | 226 | 172 | $625.66 | |
| 76830 | Ultrasound, transvaginal | 22 | 12 | $580.65 |
| 85652 | 371 | 322 | $571.47 | |
| 97162 | 49 | 40 | $552.05 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,295 | 3,609 | $475.28 |
| 87207 | 65 | 29 | $299.64 | |
| Q3014 | Telehealth originating site facility fee | 29 | 27 | $283.67 |
| 80076 | 75 | 69 | $275.95 | |
| 88342 | 71 | 50 | $264.11 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 14 | 12 | $259.08 |
| 97535 | Self-care/home management training, each 15 minutes | 33 | 15 | $257.64 |
| 80061 | Lipid panel | 49 | 39 | $242.73 |
| J3490 | Unclassified drugs | 7,064 | 2,648 | $229.02 |
| J7030 | Infusion, normal saline solution , 1000 cc | 9,073 | 6,294 | $202.79 |
| 97166 | 20 | 15 | $196.90 | |
| 84481 | 13 | 12 | $180.80 | |
| 36592 | 84 | 59 | $177.00 | |
| 88304 | 97 | 83 | $169.32 | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 409 | 324 | $158.07 |
| 84156 | 45 | 40 | $111.37 | |
| 86308 | 17 | 13 | $95.10 | |
| 36415 | Collection of venous blood by venipuncture | 7,476 | 5,112 | $84.31 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,060 | 3,051 | $72.33 |
| 90715 | 14 | 13 | $68.85 | |
| 84460 | 15 | 14 | $44.31 | |
| A9270 | Non-covered item or service | 6,610 | 3,352 | $43.82 |
| 96376 | 1,417 | 810 | $42.41 | |
| 84132 | 19 | 15 | $39.76 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 5,144 | 3,356 | $38.54 |
| 82553 | 15 | 12 | $35.50 | |
| 72100 | 29 | 25 | $19.24 | |
| 73130 | 34 | 25 | $18.68 | |
| J2704 | Injection, propofol, 10 mg | 3,453 | 2,002 | $7.21 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 3,035 | 2,450 | $5.11 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 5,104 | 4,051 | $4.61 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,947 | 2,974 | $4.46 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 821 | 522 | $2.17 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 6,064 | 4,319 | $0.78 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,022 | 704 | $0.30 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 28 | 25 | $0.28 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 1,943 | 1,348 | $0.02 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 695 | 514 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 180 | 153 | $0.00 |
| 73110 | 13 | 12 | $0.00 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 403 | 282 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 344 | 181 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 236 | 92 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 206 | 184 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 36 | 34 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 13 | 13 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 13 | 13 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 2,680 | 1,047 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,077 | 630 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 263 | 118 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 347 | 274 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 978 | 637 | $0.00 |
| 94760 | 440 | 213 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,262 | 870 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 224 | 180 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 64 | 51 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 134 | 119 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 50 | 47 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 49 | 41 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 123 | 76 | $0.00 |
| C1769 | Guide wire | 46 | 43 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 15 | 14 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 101 | 70 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 61 | 31 | $0.00 |
| 74019 | 54 | 49 | $0.00 | |
| C1726 | Catheter, balloon dilatation, non-vascular | 14 | 13 | $0.00 |